{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:25:28Z","timestamp":1770409528199,"version":"3.49.0"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p>We have examined the toxicity and overall outcome of the Medical Research Council UKALL R1 protocol for 256 patients with relapsed childhood acute lymphoblastic leukaemia (ALL). Second remission was achieved in over 95% of patients. Two patients died during induction and seven patients died of resistant disease. The overall actuarial event\u2010free survival (EFS) at 5 years for all patients experiencing a first relapse was 46% (95% CI 40\u201352). Duration of first remission, site of relapse, age at diagnosis and sex emerged as factors of prognostic significance. Five\u2010year EFS was only 7% for children relapsing in the bone marrow within 2 years of diagnosis, but was 77% for those relapsing without bone marrow involvement &gt;\u20032.5 years from diagnosis. All analyses in this report are by treatment received. For those receiving chemotherapy alone, the 5\u2010year EFS was 48%; for autologous bone marrow transplantation (BMT), the 5\u2010year EFS was 47%; for unrelated donor BMT, it was 52%; and for related donor BMT, the 5\u2010year EFS was 45%. The groups, however, were not comparable with respect to risk factor profile, and therefore direct comparison of EFS is misleading. Adjustment for time to transplant and prognostic factors was used to reduce the effects of biases between treatment groups, but did not suggest benefit for any particular treatment. There was failure of our planned randomization scheme in this trial with only 9% of those eligible being randomized, which highlights the difficulties in running randomized trials especially in patients who have relapsed from a previous trial. The optimal treatment for relapsed ALL therefore remains uncertain. Alternative approaches are clearly needed for those with early bone marrow relapse if outcome is to improve.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01891.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:21:59Z","timestamp":1047363719000},"page":"531-543","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study"],"prefix":"10.1111","volume":"108","author":[{"family":"Lawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Oakhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Eden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Darbyshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the mrc childhood leukaemia working party","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,20]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"75","article-title":"Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission","volume":"1","author":"Bacigalupo A.","year":"1986","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.8.3247.3247"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311902"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950180305"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V81.6.1651.1651","article-title":"Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia","volume":"81","author":"Billett A.L.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_7_2","first-page":"332a","article-title":"Outcome of children with B\u2010lineage acute lymphoblastic leukemia (ALL) in first bone marrow relapse","volume":"90","author":"Billett A.L.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00825.x"},{"key":"e_1_2_5_9_2","first-page":"515","article-title":"Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation","volume":"15","author":"Borgmann A.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92710-7"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712243172602"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950210703"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90128-0"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V85.9.2354.bloodjournal8592354","article-title":"Unrelated bone marrow donor transplants for children with acute lymphoblastic leukemia or myelodysplasia","volume":"85","author":"Casper J.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390904"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00776.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91387-5"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03251.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.12.3774"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"383a","DOI":"10.1182\/blood.V86.4.1636.bloodjournal8641636","article-title":"Unrelated donor bone marrow transplantation for acute leukemia in children","volume":"86","author":"Davies S.M.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V78.10.2780.2780","article-title":"Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM\u2010 and CoALL\u2010Protocols: results of the German Co\u2010operative study","volume":"78","author":"Dopfer R.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980401)82:7<1387::aid-cncr24>3.3.co;2-6"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03252.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4413253.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700827"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.1166","article-title":"Six\u2010year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL\u2010REZ BFM 85). A relapse study of the BFM group","volume":"78","author":"Henze G.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_5_27_2","first-page":"255","article-title":"Case\u2013control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children","volume":"15","author":"Hoogerbrugge P.M.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198110083051502"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303043280901"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1002914.x"},{"key":"e_1_2_5_31_2","first-page":"40","article-title":"Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia","volume":"18","author":"Messina C.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701052"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240202"},{"key":"e_1_2_5_34_2","first-page":"43","article-title":"Which children do benefit from bone marrow transplant?","volume":"18","author":"Niethammer D.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1834.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503233321217"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.831.831"},{"key":"e_1_2_5_39_2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V81.3.602.602","article-title":"Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"81","author":"Sadowitz P.D.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1594"},{"key":"e_1_2_5_41_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V70.1.324.324","article-title":"Marrow transplantation for children with acute lymphoblastic leukemia in second remission","volume":"70","author":"Sanders J.E.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_42_2","unstructured":"SAS Procedures Guide(1990)Wilcoxon 2 Sample Test Mantel Haenszel Test for Trend and Fisher's Exact Test Version 6 3rd edn. SAS Institute Cary NC."},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950250503"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.4.672"},{"key":"e_1_2_5_45_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.1995.13.2.352","article-title":"Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten\u2010year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association","volume":"13","author":"Uderzo C.","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08416.x"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03253.x"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00676.x"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.2.271"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01891.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T16:43:55Z","timestamp":1698597835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01891.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01891.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01891.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"2002-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}